FIGS Ansoff Matrix
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
Explore the Complete Growth Strategy Behind the Preview
This FIGS Amsoff Matrix Analysis shows the company's growth options across market penetration, market development, product development, and diversification in one clear framework. This page already includes a real preview of the actual deliverable, so you can see the content and format before buying. Purchase the full version to get the complete ready-to-use analysis.
Market Penetration
Repeat purchase flywheel
FIGS'"'"' repeat purchase flywheel fits market penetration: it can push the same healthcare worker to buy again inside the same 12-month scrub cycle, instead of chasing a new market. In FY2025, that matters because FIGS already sells into a defined, repeat-need base, so a small lift in reorder rate can move revenue as much as new-customer adds. This is classic penetration: more buys from the same buyers.
Basket building across 5 product families
Basket building across FIGS' 5 product families lifts market share by increasing items per order in scrubs, underscrubs, outerwear, loungewear, and accessories. That pushes average order value up without needing a new customer base. In FY2025, the strategy matters because FIGS already sells a focused, premium wardrobe, so more categories per basket make the brand harder to replace. A fuller kit also raises repeat-buy potential and lowers churn.
Community-led loyalty and referrals
FIGS still wins with a community-first model that speaks directly to clinicians, which helps lower acquisition friction and keep repeat buys high. In FY2025, that matters more than broad ads because trust in peer-led brands can move both women and men in the same hospitals and clinics. Referral loops and loyal wearers turn one buyer into many, so market penetration scales with each shift change and shared uniform need.
Owned-channel conversion discipline
FIGS depends on its own e-commerce channel, so it controls traffic, merchandising, and pricing. That makes conversion discipline a core Market Penetration lever: even a small lift in site conversion can turn the same 2025 and 2026 traffic into more sales without adding much marketing spend.
Better search, fit guidance, and checkout flow matter most because they reduce drop-off on owned visits and improve monetization of paid and organic traffic.
Promotion timing and brand defense
In FY2025, FIGS can use selective promotions and limited drops to defend share against larger scrub brands and lower-priced rivals. The move should stay tactical, not constant, so the brand keeps its premium price signal. That matters when demand softens or a rival pushes discounting, because fast but narrow response can protect volume in the core market. Limited offers also help test price sensitivity without training buyers to wait for markdowns.
FIGS Gains Share by Selling More to the Same Clinicians
FIGS' market penetration in FY2025 comes from selling more to the same clinician base: repeat buys, higher items per order, and tighter conversion on owned e-commerce. The play is simple: protect the premium brand, lift reorder rate, and grow share inside a fixed scrub cycle.
| FY2025 lever | Penetration effect |
|---|---|
| Repeat purchase | More buys from same workers |
| Basket expansion | Higher average order value |
| Owned channel | Better conversion control |
What is included in the product
Detailed Word Document
Editable Excel File
Market Development
Cross-border e-commerce expansion
FIGS can use cross-border e-commerce to sell the same scrub line into more countries, with 2025 digital retail making this a low-fixed-cost test. The move is simple: keep the core product, but localize shipping, duties, and site presentation to fit each market.
That lowers risk versus opening stores, and it lets FIGS learn where demand is strongest before larger bets. With one product line and many regions, the company can scale faster without adding much inventory complexity.
New clinician segments beyond hospitals
FIGS can widen demand beyond hospitals by targeting allied health, dental, veterinary, and student buyers, all of whom wear the same scrub and lab-coat categories. This is a clean market-development move because it lifts addressable demand without changing the product architecture.
The U.S. healthcare workforce is still above 20 million, and those adjacent segments add more buyers who need the same core uniforms but sit outside FIGS' hospital-heavy base. That matters because even small share gains across these groups can add revenue without new manufacturing complexity.
Institutional and team ordering channels
In 2025, FIGS can widen market reach by selling through clinic, health system, and employer uniform programs, adding a B2B route next to direct consumer sales. Larger group orders usually cut per-order selling costs and improve repeat replenishment visibility. That matters in a market tied to more than 20 million U.S. healthcare workers, where steady uniform demand is easier to plan than one-off purchases.
Metro-by-metro demand building
Metro-by-metro demand building fits FIGS' market development play: pop-ups, events, and local activations can enter new cities without a full store buildout. In 2025 and 2026, that matters because it tests demand before capital spend and can reveal dense pockets of nurses, doctors, and other healthcare workers. One clean example is to pilot in hospital-heavy metros, then scale only where repeat traffic and conversion prove out.
Localized fit and logistics
Localized fit and logistics matter in market development because FIGS can't just ship scrubs abroad and expect repeat orders. A single design base can stay consistent, while market-specific sizing, returns, duties, and last-mile delivery reduce friction for first-time buyers. In apparel, fit drives online conversion, and international shoppers are even less tolerant of delays or size mismatch, so reliable delivery and clear size guidance protect margin and trust.
FIGS Expands by Selling More Scrubs to More Buyers
In 2025, FIGS' market development fits selling the same scrubs into new countries and new buyer groups, not changing the product. That works because the U.S. healthcare workforce is still over 20 million, so small share gains can add real sales.
B2B uniform programs, clinic sales, and metro pilots can widen reach with lower fixed cost than new stores.
Fit, duties, and fast delivery matter most in international demand.
| 2025 market development lever | Why it matters |
|---|---|
| Cross-border e-commerce | Low-capex entry |
| Adjacent buyers | More demand pools |
| B2B uniform programs | Higher order visibility |
What You See Is What You Get
FIGS Reference Sources
This is the actual FIGS Amsoff Matrix Analysis document you'll receive upon purchase – no sample version, just the real file. The preview below is taken directly from the full report, so what you see is exactly what you'll get. Once purchased, the complete FIGS analysis is unlocked for immediate use.
Product Development
Expand beyond the core scrub set
In 2025, FIGS can deepen wallet share by expanding beyond the core scrub set into underscrubs, outerwear, loungewear, socks, and shoes. Product development fits its broader basket strategy and raises relevance with the same healthcare customers. That is the cleanest way to monetize one market more deeply.
FIGS already sells more than a single-scrub lineup, so each add-on can lift average order value and repeat purchase rates. Wider assortments also help FIGS compete on full workwear, not just uniforms.
Upgrade fabric and performance features
FIGS can keep upgrading stretch, durability, softness, and recovery in its fabric, because those details drive all-day comfort in long shifts. In FY2025, that matters even more as premium workwear faces tighter competition and slower category growth, so better performance helps protect repeat buys and brand loyalty. Product refreshes also support FIGS' premium price point, since customers will pay more for scrubs that feel better and last longer.
Broaden fits, sizes, and gender coverage
FIGS can use product development to broaden fit architecture for women and men across more sizes, which matters because apparel fit issues drive a large share of online returns and return rates can reach 20% to 30%. Better size consistency should lift first-order conversion and cut reverse-logistics costs, which hit margin fast in e-commerce. It also supports repeat demand in a category where fit is a top purchase driver.
Seasonal colorways and capsule drops
Seasonal colorways and capsule drops let FIGS refresh the assortment without changing the core scrub fit or fabric, so the product stays familiar but feels new. In a utility-led category where repeat buying matters, that low-risk novelty can lift urgency, site visits, and social sharing. It also supports higher-margin demand with limited-edition scarcity instead of heavy product redesign, which fits a 2025 growth play focused on repeat traffic and brand heat.
Function-first lifestyle adjacencies
FIGS can add function-first lifestyle adjacencies like layered basics and travel-friendly pieces to give healthcare workers more use cases without drifting from the core uniform buyer. This fits the 2025 FY growth play because it lifts average order value and repeat purchase by adding off-duty occasions, not just more SKUs. The bet works when each launch still solves a shift-to-street problem, so the brand stays useful and stays close to its core customer.
FIGS' FY2025 Growth Formula: Better Fit, Bigger Baskets
In FY2025, FIGS' product development should focus on more than scrubs: add-ons, better fit, and shift-to-street pieces can lift repeat buys and average order value. Cleaner size architecture matters too, since fit issues can drive 20% to 30% return rates. Seasonal color drops keep demand fresh without changing core comfort.
| FY2025 signal | Use in product development |
|---|---|
| 20% to 30% | Return-rate risk from fit |
| Repeat buys | Broader basket growth |
Diversification
Still centered on one core brand
FIGS is still centered on one core brand, so diversification remains weak versus penetration and product expansion. In 2025, 100% of revenue still came from the FIGS brand, with no second standalone business to offset swings in healthcare demand. That makes the 2026 growth plan mostly adjacent, using the same brand and customer base rather than building a new revenue engine.
Accessories as a second revenue layer
Accessories are FIGS' most realistic diversification path: in recent years the company has already expanded beyond core scrubs into socks, underscrubs, outerwear, and lifestyle items, creating a second revenue layer without entering a new market. That matters because FIGS still depends on a narrow professional wear base, so even a modest mix shift can soften scrub-only demand swings.
In 2025, this is a low-risk way to widen average order value and repeat buys, since accessories usually carry lower size and fit barriers than uniforms. It is diversification only at the margin, but it can improve resilience and reduce concentration risk.
Broader workwear beyond the hospital floor
FIGS can push beyond the hospital floor into other professional uniform markets, like dental, veterinary, and wellness settings, where comfort and durability matter. That expands both new customers and new use cases, but it is still more speculative than FIGS' core healthcare business in March 2026; FIGS ended fiscal 2025 with about $500 million in annual revenue, so a new category must prove scale fast. The upside is real, but brand fit, channel reach, and repeat purchase rates still need proof.
Services and content as optionality
FIGS's community-led brand gives it optionality to build services, content, or employer-facing tools around the apparel core. If those ideas move beyond marketing, they could open a second monetization stream and reduce dependence on scrub sales. For now, they are strategic options, not material revenue drivers.
Long-shot adjacency, not a new identity
True diversification would mean FIGS sells to a new customer for a new job, not just a new color, fabric, or silhouette. That is why this sits in adjacency, not a new identity: the brand still leans on healthcare workers, and its FY2025 economics likely reward staying close to that core. The bar for real diversification is much higher, because it must build new demand, new use cases, and new buying habits, not just more SKUs.
FIGS' FY2025 growth still leans on one brand
FIGS diversification is still limited in FY2025: about $500 million revenue came 100% from one brand, so there is no second business to cushion demand swings. Accessories are the clearest step, since socks, underscrubs, and outerwear widen spend without leaving the core customer. True diversification would need new buyers and new use cases, not just more SKUs.
| FY2025 signal | Read |
|---|---|
| Revenue | About $500m |
| Brand mix | 100% FIGS |
Frequently Asked Questions
Repeat purchases drive FIGS market penetration most. The company already sells into 1 core healthcare-use case through 1 owned digital channel, so the real upside comes from higher reorder frequency and larger baskets. Turning a 1-time buyer into 2 or 3 annual orders matters more than chasing a brand-new market.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.